Chart calendar Merck & Co., Inc.

bd6f4b7235526355c0a6e93a969140.XS_RXmvPIFXareZ5yCmX2Vt8gCPNcZANzb-p0olFtVM.BXmOB1OsSCKzyJQxu1rViDNL-GmjFdVrmtvxhMcR2TI1RfxvM5dCY4j0rw~92f8cb85f617cbbc832fef8890219d30

Upcoming events on Merck & Co., Inc.

15/03/2026

30/04/2026

Q1 2026 Earnings Release

30/04/2026

Q1 2026 Earnings Call

03/08/2026

Q2 2026 Earnings Release

04/08/2026

Q2 2026 Earnings Call

29/10/2026

Q3 2026 Earnings Release

29/10/2026

Q3 2026 Earnings Call

03/02/2027

Q4 2026 Earnings Release (Projected)

28/04/2027

Q1 2027 Earnings Release (Projected)

02/08/2027

Q2 2027 Earnings Release (Projected)

03/11/2027

Q3 2027 Earnings Release (Projected)

Past events on Merck & Co., Inc.

03/02/2026

Q4 2025 Earnings Call

03/02/2026

Q4 2025 Earnings Release

13/01/2026

J.P. Morgan Healthcare Conference

14/12/2025

03/12/2025

Citi Global Healthcare Conference

03/12/2025

Clinical Trials on Alzheimer Disease Conference - Abstract Number P249

03/12/2025

Clinical Trials on Alzheimer Disease Conference - Abstract Number P112

02/12/2025

Evercore Healthcare Conference

01/12/2025

Clinical Trials on Alzheimer Disease Conference - Abstract Number P112

20/11/2025

Jefferies Global Healthcare Conference

17/11/2025

Acquisition of Cidara Therapeutics, Inc. by Merck & Co., Inc. Call

10/11/2025

American Heart Association Meeting - Abstract Number: 4341629

09/11/2025

American Heart Association Meeting

09/11/2025

American Heart Association Meeting - Abstract Number: 4391641

09/11/2025

American Heart Association Meeting - Abstract Number: 4359798

08/11/2025

American Heart Association Meeting - Abstract Number: 4391578

08/11/2025

American Heart Association Meeting - Abstract Number: 4365782

08/11/2025

American Heart Association Meeting - Abstract Number: 4387511

30/10/2025

Q3 2025 Earnings Call

30/10/2025

Q3 2025 Earnings Release

Past dividends on Merck & Co., Inc.

14/12/2025

Quarterly 0.85 USD

14/09/2025

Quarterly 0.81 USD

15/06/2025

Quarterly 0.81 USD

16/03/2025

Quarterly 0.81 USD

15/12/2024

Quarterly 0.81 USD

15/09/2024

Quarterly 0.77 USD

16/06/2024

Quarterly 0.77 USD

13/03/2024

Quarterly 0.77 USD

13/12/2023

Quarterly 0.77 USD

13/09/2023

Quarterly 0.73 USD

13/06/2023

Quarterly 0.73 USD

13/03/2023

Quarterly 0.73 USD

13/12/2022

Quarterly 0.73 USD

13/09/2022

Quarterly 0.69 USD

13/06/2022

Quarterly 0.69 USD

13/03/2022

Quarterly 0.69 USD

13/12/2021

Quarterly 0.69 USD

13/09/2021

Quarterly 0.65 USD

13/06/2021

Quarterly 0.65 USD

Annual results

Fiscal PeriodDecember 2022 2023 2024 2025 2026 2027
Net sales
Million USD
Released
Forecast
Spread
59 283
59 144
0.24%
60 115
59 938
0.3%
64 168
63 997
0.27%
65 011
64 779
0.36%

66 708


70 445

EBITDA
Million USD
Released
Forecast
Spread
26 431
24 588
7.5%
10 083
9 362
7.71%
27 897
26 650
4.68%
0,00
29 685
-

21 376


32 578

EBIT
Million USD
Released
Forecast
Spread
22 522
22 363
0.71%
6 211
6 066
2.4%
23 398
23 593
-0.83%
26 779
26 730
0.18%

18 150


29 816

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
16 444
17 389
-5.44%
1 889
2 857
-33.89%
19 936
21 364
-6.68%
21 067
22 876
-7.91%

13 960


26 343

Net income
Million USD
Released
Forecast
Spread
14 519
14 827
-2.07%
365
1 682
-78.3%
17 117
17 500
-2.19%
18 254
19 815
-7.88%

10 423


21 504

EPS
USD
Released
Forecast
Spread
5,71
5,87
-2.73%
0,14
0,56
-75.16%
6,74
7,01
-3.82%
7,28
7,74
-5.99%

4,36


8,79

Announcement Date02/02/2301/02/2404/02/2503/02/26

Quarterly results

Fiscal PeriodSeptember 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4 2026 Q1 2026 Q2 2026 Q3 2026 Q4 2027 Q1 2027 Q2 2027 Q3
Net sales
Million USD
Released
Forecast
Spread
15 775
15 204
3.75%
16 112
15 844
1.69%
16 657
16 514
0.87%
15 624
15 507
0.76%
15 529
15 331
1.29%
15 806
15 873
-0.42%
17 276
16 978
1.76%
16 400
16 206
1.2%

15 909


16 407


17 596


16 924


16 985


17 730


19 160

EBITDA
Million USD
Released
Forecast
Spread
7 367
6 562
12.27%
7 177
7 367
-2.57%
5 466
5 999
-8.89%
6 422
7 737
-16.99%
7 722
6 882
12.2%
7 484
7 160
4.52%
8 710
8 313
4.77%

7 843


-1 688


7 402


8 253


7 072










EBIT
Million USD
Released
Forecast
Spread
6 383
5 808
9.91%
6 659
6 519
2.14%
4 913
5 046
-2.63%
5 225
5 140
1.66%
6 623
6 533
1.38%
6 365
6 206
2.56%
7 556
7 139
5.84%
6 236
6 134
1.66%

-2 519


6 573


7 571


6 542










Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
5 670
5 267
7.66%
6 006
6 023
-0.29%
4 090
4 535
-9.82%
4 170
4 641
-10.15%
5 903
5 880
0.4%
4 999
5 672
-11.86%
6 745
6 465
4.32%
3 420
4 751
-28.02%

-3 581


5 430


6 551


5 614










Net income
Million USD
Released
Forecast
Spread
4 762
4 414
7.88%
5 455
4 942
10.38%
3 157
3 419
-7.66%
3 743
3 700
1.16%
5 079
4 983
1.93%
4 427
4 651
-4.81%
5 785
5 155
12.22%
2 963
4 341
-31.74%

-3 740


4 423


5 252


4 628










EPS
USD
Released
Forecast
Spread
1,87
1,79
4.45%
2,14
1,93
10.86%
1,24
1,43
-13.39%
1,48
1,49
-0.58%
2,01
1,93
3.97%
1,76
1,84
-4.45%
2,32
2,06
12.85%
1,19
1,68
-29.16%

-1,51


1,74


2,11


1,86










Announcement Date25/04/2430/07/2431/10/2404/02/2524/04/2529/07/2530/10/2503/02/26-------
17/02/2026

Q4 2025 Earnings Release

17/02/2026

Q4 2025 Earnings Release (Projected)

18/02/2026

Q4 2025 Earnings Release (Projected)

18/02/2026

Q4 2025 Earnings Release (Projected)

18/02/2026

Q4 2025 Earnings Release (Projected)

19/02/2026

Q4 2025 Earnings Release

19/02/2026

Q4 2025 Earnings Release

19/02/2026

Q4 2025 Earnings Release (Projected)

20/02/2026

Q4 2025 Earnings Release

22/02/2026

Q4 2025 Earnings Release

Past sector events for Merck & Co., Inc.

13/02/2026

Q3 2026 Earnings Release

13/02/2026

Q3 2026 Earnings Release

13/02/2026

Q3 2026 Earnings Release

13/02/2026

Q3 2026 Earnings Release

13/02/2026

Q3 2026 Earnings Release

13/02/2026

Q3 2026 Earnings Release

12/02/2026

Q3 2025 Earnings Release

12/02/2026

Q3 2025 Earnings Release

12/02/2026

Q4 2025 Earnings Release

12/02/2026

Q4 2025 Earnings Release

Quarterly revenue - Rate of surprise

Net sales - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. MRK Stock
  4. Calendar Merck & Co., Inc.